Compare clinical-trial data collection by the workflow required: participant forms and follow-up, or site-entered eCRFs, clinical queries and database management. WeGuide is included for participant-data collection and ongoing engagement, with connections to a dedicated EDC when additional clinical-data workflows are needed. Each feature links to its public source.
Best forResearch teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Updated Nov 13, 20269 tools compared
EDC
What is an EDC system?
EDC stands for electronic data capture. These systems hold the structured clinical data collected in a study, often through electronic case report forms completed by research sites. They help data teams check entries, resolve questions and prepare the dataset for analysis.
See documented feature support at a glance. Select a symbol for the explanation and source. Double checks indicate documented extra capabilities; unknown does not mean unavailable.
Products are not ranked. Table order is chosen for each guide and does not indicate a recommendation.
Columns 6 of 6
Feature 1 of 6
Select a symbol to read its evidence and source. Scroll sideways for all features.
Documented feature support for each product. Symbols describe individual features, not overall product ratings.
Drag-and-drop study build and mid-study changes with no downtime are both stated.
Extended support means: Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Medidata states that Rave deploys mid-study changes with no downtime and that studies are built with drag-and-drop design and libraries of pre-validated eCRFs.
Trial position statements are customer-only; listed ISO/SOC claims do not establish public document access.
Supported means: Relevant trial compliance or security controls are stated, with their scope identified.
Medidata lists ISO 27001:2022, ISO 27017, ISO 27018, ISO 27701 and a SOC 2+ Type II audit, and provides 21 CFR Part 11 position statements to customers.
The vendor reports EDC study and participant figures across a stated country count.
Extended support means: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs.
Self-build and audited mid-study edits are stated; uninterrupted live use is not claimed.
Supported means: Study setup or post-go-live study changes are described.
Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.
Updates avoid extended downtime; the note does not establish uninterrupted live use.
Supported means: Study setup or post-go-live study changes are described.
Medrio describes a no-code drag-and-drop builder with a template library and says updates deploy without data migration, vendor delays or extended downtime.
Live-study versioning is documented; uninterrupted changes are not established.
Supported means: Study setup or post-go-live study changes are described.
Oracle documents versioned changes to live studies, including Advanced Study Versioning and several versions in production, but we could not load an Oracle page that states changes run without downtime.
Electronic signatures and audit trails establish base controls; a Clinical One Part 11 statement was not found.
Supported means: Relevant trial compliance or security controls are stated, with their scope identified.
Oracle documents electronic signatures and audit-trail datasets for Clinical One, and its cloud compliance page lists ISO 27001 attestations by line of business, but we found no public Part 11 statement specific to Clinical One.
Native randomization, supply and coding are documented; eCOA and eConsent use partners.
Supported means: EDC connects to another named clinical-trial module.
Clinical One combines data collection with randomization and trial supply management, Central Coding and Analytics; eCOA and eConsent come through partner integrations.
Named research deployments establish base support; the evidence does not establish full EDC deployment counts.
Supported means: Published product or wider-platform adoption, or a named clinical-research deployment.
Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.
Study configuration is documented; a no-interruption EDC amendment workflow is not.
Supported means: Study setup or post-go-live study changes are described.
Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.
Public statements establish the documented-support level; no public certificate or audit report establishes extended support.
Supported means: Relevant trial compliance or security controls are stated, with their scope identified.
WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.
Connected participant modules and external EDC exchange are documented; the full native-suite definition is not met.
Supported means: EDC connects to another named clinical-trial module.
Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.
The consortium reports institution and project adoption across a stated country count.
Extended support means: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research.
Part 11 support depends on institutional setup; the note also identifies a non-compliant host.
Supported means: Relevant trial compliance or security controls are stated, with their scope identified.
Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant.
Amendments avoid system shutdown, but deployment includes a brief casebook lockout.
Supported means: Study setup or post-go-live study changes are described.
Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.
Part 11 eSignature and ISO/SOC statements are given; public certificate or report access is not established.
Supported means: Relevant trial compliance or security controls are stated, with their scope identified.
Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.
The API uses an ODM-like model; the only stated ODM export is legacy.
Supported means: An API for clinical data exchange is stated.
Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.
The vendor reports study, participant and site adoption across a stated country count.
Extended support means: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Viedoc reports 8,000 studies, 1.6M participants and 30K sites in 75+ countries, and Everest Group rated it a Leader in 2024.
Native randomization, trial supply, medical coding and ePRO are all named.
Extended support means: Native randomization, trial supply management, medical coding, and either eCOA or ePRO are documented alongside EDC.
Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.
Every product uses the same definitions. Double checks indicate documented extra capabilities in that column; they do not indicate an overall winner. Unknown means the available sources do not establish support.
Track record in regulated multi-site trials
Supported: Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support: Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Study build and mid-study changes
Supported: Study setup or post-go-live study changes are described.
Extended support: Study setup is described, and post-go-live changes explicitly avoid interrupting live study use.
Compliance and security
Supported: Relevant trial compliance or security controls are stated, with their scope identified.
Extended support: Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Platform breadth
Supported: EDC connects to another named clinical-trial module.
Extended support: Native randomization, trial supply management, medical coding, and either eCOA or ePRO are documented alongside EDC.
APIs and data standards
Supported: An API for clinical data exchange is stated.
Extended support: An API plus data exchange in a named CDISC format are documented.
Published pricing and terms
Supported: A pricing basis, model or contract terms are published beyond contact sales.
Extended support: Production prices or a free production option are published, with amounts and conditions stated.
Read the detailed feature comparison
Columns 6 of 6
Feature 1 of 6
Select a feature label for its details and source. Scroll sideways for all features.
Feature statements for each product, with public sources. Products appear in editorial order.
Drag-and-drop; no-downtime changes stated — details and source
Medidata states that Rave deploys mid-study changes with no downtime and that studies are built with drag-and-drop design and libraries of pre-validated eCRFs.
ISO/SOC listed; Part 11 statements for customers — details and source
Medidata lists ISO 27001:2022, ISO 27017, ISO 27018, ISO 27701 and a SOC 2+ Type II audit, and provides 21 CFR Part 11 position statements to customers.
Low-code self-build + audited mid-study edits — details and source
Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.
No-code; updates without migration stated — details and source
Medrio describes a no-code drag-and-drop builder with a template library and says updates deploy without data migration, vendor delays or extended downtime.
Live versioning; downtime claim not verified — details and source
Oracle documents versioned changes to live studies, including Advanced Study Versioning and several versions in production, but we could not load an Oracle page that states changes run without downtime.
Audit trails documented; Part 11 not found — details and source
Oracle documents electronic signatures and audit-trail datasets for Clinical One, and its cloud compliance page lists ISO 27001 attestations by line of business, but we found no public Part 11 statement specific to Clinical One.
Native RTSM/coding; eCOA/eConsent via partners — details and source
Clinical One combines data collection with randomization and trial supply management, Central Coding and Analytics; eCOA and eConsent come through partner integrations.
Named clinical research deployments — details and source
Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.
Configurable study forms, logic and validation — details and source
Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.
Trial/privacy controls and ISO certification stated — details and source
WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.
Consent, questionnaires and optional EDC connections — details and source
Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.
8,526 institutions; nonprofit/academic focus — details and source
The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research.
Part 11 depends on institution; varies by host — details and source
Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant.
Amendments without migration; brief casebook lockout — details and source
Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.
ISO/SOC listed; Part 11 eSignature stated — details and source
Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.
CDMS API; ODM casebook export is legacy — details and source
Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.
Native supply/coding/ePRO; remote consent, no CTMS — details and source
Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.
Medidata Rave EDCStudy fit: large sponsors and CROs running global Phase II and III programs that want EDC, RTSM, coding and eCOA from one vendor.
CastorStudy fit: academic groups, biotechs and device teams running investigator-initiated or mid-size studies who want to build studies themselves.
MedrioStudy fit: small and mid-size sponsors and CROs that want a no-code EDC with RTSM, eCOA and eConsent from one vendor.
OpenClinicaStudy fit: academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.
Oracle Clinical OneStudy fit: large sponsors and CROs that want data collection and randomization and supply management on one Oracle platform.
WeGuideStudy fit: clinical trials and research studies that need participant-data collection and ongoing engagement, with consent, forms, ePRO, follow-up and connections to existing systems
REDCapStudy fit: academic and non-profit teams running investigator-initiated studies, as a free baseline.
Veeva EDCStudy fit: sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
ViedocStudy fit: sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users.
No prices published; the Patient Cloud service descriptions publish contract terms (devices on a rental basis, caps on fee adjustments, early-termination fees)
Launch $750/month (EDC only, max 150 participants and 3 sites, no API); Core $3,000/month per study; Advanced $3,750/month per study (12-month contracts); services $275-$350/hour
Named REDCap, Castor and Medidata Rave connections. Integration methods, field mapping and study workflows are configured for the project; REST and FHIR are listed as possible methods.
Medidata states that Rave deploys mid-study changes with no downtime and that studies are built with drag-and-drop design and libraries of pre-validated eCRFs.
Medidata lists ISO 27001:2022, ISO 27017, ISO 27018, ISO 27701 and a SOC 2+ Type II audit, and provides 21 CFR Part 11 position statements to customers.
No prices published; the Patient Cloud service descriptions publish contract terms (devices on a rental basis, caps on fee adjustments, early-termination fees)Source
Security certifications
ISO 27001:2022, ISO 27017:2015, ISO 27018:2019, ISO 27701:2019, SOC 2+ Type IISource
Headquarters
New York, NY (350 Hudson Street, per ISO certificate)Source
Less suitable for teams that need published prices or a self-serve contract for a single small study.
Study fit: academic groups, biotechs and device teams running investigator-initiated or mid-size studies who want to build studies themselves.
Castor has a large published study footprint and strong certifications, and teams can build studies without vendor help. It offers fewer native modules than the enterprise suites, and Everest Group placed it as a Major Contender rather than a Leader in 2024.
Track record in regulated multi-site trials
Castor reports more than 31,900 studies with 9.5 million participants in 171 countries, but its pages give no evidence of global Phase III programs.
Castor offers self-service build with a low-code eCRF builder and reusable templates, and says forms can be edited mid-study with audit trails and separate test environments, without a no-downtime claim.
Medrio describes a no-code drag-and-drop builder with a template library and says updates deploy without data migration, vendor delays or extended downtime.
Study fit: academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.
OpenClinica is the only commercial EDC here with public list prices, and it documents an ODM-based REST API. It has fewer native modules than the enterprise suites, and Everest Group rated it a Major Contender, not a Leader, in 2024.
Track record in regulated multi-site trials
OpenClinica says its technology has powered over 15,000 studies and more than three million patients.
Launch $750/month (EDC only, max 150 participants and 3 sites, no API); Core $3,000/month per study; Advanced $3,750/month per study (12-month contracts); services $275-$350/hourSource
Compliance claims
States 21 CFR Part 11, ICH GCP E6(R2), HIPAA and GDPR complianceSource
Security certifications
SOC 2 Type II certified; ISO 27001 certifiedSource
API and integrations
REST clinicaldata API: import as CDISC ODM 1.3.2 XML, retrieve as ODM XML or JSON, bearer-token authSource
Less suitable for sponsors that need native trial supply management and medical coding in the EDC platform.
Study fit: large sponsors and CROs that want data collection and randomization and supply management on one Oracle platform.
Clinical One unifies EDC and RTSM and has a well-documented API. Public information gaps include a study count, a Part 11 statement specific to Clinical One and prices; we could not find these in the sources checked.
Track record in regulated multi-site trials
Everest Group rated Oracle a Leader in its 2024 EDC assessment, but we found no published Clinical One study or customer count.
Oracle documents versioned changes to live studies, including Advanced Study Versioning and several versions in production, but we could not load an Oracle page that states changes run without downtime.
Oracle documents electronic signatures and audit-trail datasets for Clinical One, and its cloud compliance page lists ISO 27001 attestations by line of business, but we found no public Part 11 statement specific to Clinical One.
Clinical One combines data collection with randomization and trial supply management, Central Coding and Analytics; eCOA and eConsent come through partner integrations.
Study fit: clinical trials and research studies that need participant-data collection and ongoing engagement, with consent, forms, ePRO, follow-up and connections to existing systems
WeGuide brings participant-data collection and ongoing engagement into one study program for clinical trials and research studies. Teams can run screening, consent, forms, ePRO, reminders and follow-up in a branded participant app. The Integration Engine connects existing research systems when required. If the protocol needs intensive site-entered clinical data, complex queries, medical coding or advanced database management, use an appropriate EDC alongside the participant workflow. Suitability depends on those requirements, rather than study size or phase alone.
Track record in regulated multi-site trials
Public research examples include BRACE and INHERIT. These document research use of the participant platform, rather than counts of full enterprise EDC deployments or regulatory submissions.
Study teams configure forms, question types, conditional logic, input validation and testing. This supports focused trial data collection; uninterrupted enterprise-EDC database amendments are not established by the public material.
WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.
Study programs combine participant forms, ePRO, consent and follow-up. REDCap and other EDC connections can be configured where additional clinical-data workflows require them. A native enterprise EDC, medical-coding and supply-management suite is not claimed.
Quoted per study, with hosting, support and modules included. Email hello@weguide.health for a study-specific quote; price amounts are not published.Source
Compliance claims
Supports 21 CFR Part 11 requirements (stated); EU Annex 11 not statedSource
Compliance claims
WeGuide states 21 CFR Part 11 and HIPAA support; confirm the study-specific validation scope and BAA requirements.Source
Security certifications
ISO 27001:2022 (stated; certificate not published); no SOC 2 claim foundSource
Less suitable for protocols requiring extensive in-visit eCRFs, complex data queries, medical coding, source-data verification or an enterprise database-lock workflow.
Study fit: academic and non-profit teams running investigator-initiated studies, as a free baseline.
REDCap is the free academic baseline, with open data standards and very wide adoption. It comes without vendor support, its Part 11 status depends on each institution, and sponsors and CROs cannot license it.
Track record in regulated multi-site trials
The REDCap Consortium lists 8,526 institutions in 167 countries and 2.9M projects, but REDCap is licensed to non-profits and its use is concentrated in academic research.
Vanderbilt says REDCap can be installed for 21 CFR Part 11 compliance, but this depends on each institution's setup; Penn Medicine, for example, states its REDCap is not Part 11-compliant.
Study fit: sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.
Track record in regulated multi-site trials
Veeva reports 100+ EDC customers and says eight of the top 20 biopharmas have switched to Veeva EDC, but publishes no study count.
Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.
Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.
Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.
Study fit: sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users.
Viedoc combines an Everest Group Leader rating with no-downtime study changes, strong certifications and a published pricing model. It has no native CTMS and no named eConsent module.
Track record in regulated multi-site trials
Viedoc reports 8,000 studies, 1.6M participants and 30K sites in 75+ countries, and Everest Group rated it a Leader in 2024.
Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.
This guide compares 9 products across the same feature topics. Each statement describes what the available public sources document, including limitations and study requirements.
Scope: Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
Track record in regulated multi-site trials
Study build and mid-study changes
Compliance and security
Platform breadth
APIs and data standards
Published pricing and terms
A vendor’s published claim is not independent confirmation that a product will meet your study’s needs. Check deployment, validation, integrations and commercial terms with the vendor.
Outside this comparison: Zelta (Merative), which Everest Group also rated a Leader in 2024, was not in our candidate set. REDCap Cloud is a separate commercial product from consortium REDCap and is not included here.
An electronic data capture (EDC) system replaces paper case report forms in a clinical trial. Sites enter data into electronic forms, the system checks entries, raises queries and keeps an audit trail, and the sponsor uses the cleaned data for analysis and regulatory submissions.
Which EDC systems suit global Phase III trials?
Medidata Rave EDC has the largest published footprint we found (38K+ studies). Everest Group's 2024 EDC assessment rated Medidata, Oracle, Veeva, Viedoc and Zelta (Merative) as Leaders; Medidata, Oracle, Veeva and Viedoc are compared on this page. Assess their documented capabilities against your Phase III requirements.
How much does EDC software cost?
Most vendors publish no prices. OpenClinica is the exception: its EDC-only Launch plan is $750 a month and its Core plan is $3,000 a month per study on a 12-month contract. Viedoc publishes its pricing model (per-study license, unlimited users) without prices, and REDCap is free for non-profit consortium members.
Is REDCap 21 CFR Part 11 compliant?
It can be, but not by default. Vanderbilt says REDCap can be installed for Part 11 compliance; each institution runs and validates its own installation, and some, such as Penn Medicine, state that their instance is not Part 11-compliant.
Can I change an EDC study after go-live?
Yes. Medidata, Veeva, Medrio and Viedoc state that mid-study changes deploy without system downtime, and Oracle documents versioning of live studies. Ask each vendor how an amendment affects data already entered.